144 related articles for article (PubMed ID: 8839864)
1. Interstitial deletion constitutes the major mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera.
Asimakopoulos FA; Gilbert JG; Aldred MA; Pearson TC; Green AR
Blood; 1996 Oct; 88(7):2690-8. PubMed ID: 8839864
[TBL] [Abstract][Full Text] [Related]
2. A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region.
Bench AJ; Aldred MA; Humphray SJ; Champion KM; Gilbert JG; Asimakopoulos FA; Deloukas P; Gwilliam R; Bentley DR; Green AR
Genomics; 1998 May; 49(3):351-62. PubMed ID: 9615219
[TBL] [Abstract][Full Text] [Related]
3. Detection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes.
Asimakopoulos FA; Holloway TL; Nacheva EP; Scott MA; Fenaux P; Green AR
Blood; 1996 Feb; 87(4):1561-70. PubMed ID: 8608248
[TBL] [Abstract][Full Text] [Related]
4. Clonality markers in polycythaemia and primary thrombocythaemia.
Briere J; el-Kassar N
Baillieres Clin Haematol; 1998 Dec; 11(4):787-801. PubMed ID: 10640217
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 7 long-arm deletions in myeloid disorders: terminal DNA sequences are commonly conserved and breakpoints vary.
Kere J; Donis-Keller H; Ruutu T; de la Chapelle A
Cytogenet Cell Genet; 1989; 50(4):226-9. PubMed ID: 2805820
[TBL] [Abstract][Full Text] [Related]
6. Karyotype and molecular cytogenetic studies in polycythemia vera.
Andrieux JL; Demory JL
Curr Hematol Rep; 2005 May; 4(3):224-9. PubMed ID: 15865876
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of the del(20q) chromosome in hematologic disorders.
Aatola M; Armstrong E; Teerenhovi L; Borgström GH
Cancer Genet Cytogenet; 1992 Aug; 62(1):75-80. PubMed ID: 1521239
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes.
Asimakopoulos FA; White NJ; Nacheva E; Green AR
Blood; 1994 Nov; 84(9):3086-94. PubMed ID: 7949181
[TBL] [Abstract][Full Text] [Related]
9. Molecular heterogeneity at the breakpoints of smaller 20q deletions.
Hollings PE
Genes Chromosomes Cancer; 1994 Sep; 11(1):21-8. PubMed ID: 7529043
[TBL] [Abstract][Full Text] [Related]
10. Clonality analysis using X-chromosome inactivation patterns by HUMARA-PCR assay in female controls and patients with idiopathic thrombocytosis in Taiwan.
Shih LY; Lin TL; Dunn P; Wu JH; Tseng CP; Lai CL; Wang PN; Kuo MC
Exp Hematol; 2001 Feb; 29(2):202-8. PubMed ID: 11166459
[TBL] [Abstract][Full Text] [Related]
11. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.
Baxter EJ; Scott LM; Campbell PJ; East C; Fourouclas N; Swanton S; Vassiliou GS; Bench AJ; Boyd EM; Curtin N; Scott MA; Erber WN; Green AR;
Lancet; 2005 Mar 19-25; 365(9464):1054-61. PubMed ID: 15781101
[TBL] [Abstract][Full Text] [Related]
12. Clonality analysis by HUMARA assay in Spanish females with essential thrombocythemia and polycythemia vera.
Zamora L; Espinet B; Florensa L; Besses C; Bellosillo B; Solé F
Haematologica; 2005 Feb; 90(2):259-61. PubMed ID: 15710583
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
[TBL] [Abstract][Full Text] [Related]
14. Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells.
White NJ; Nacheva E; Asimakopoulos FA; Bloxham D; Paul B; Green AR
Blood; 1994 May; 83(10):2809-16. PubMed ID: 8180377
[TBL] [Abstract][Full Text] [Related]
15. A gain-of-function mutation of JAK2 in myeloproliferative disorders.
Kralovics R; Passamonti F; Buser AS; Teo SS; Tiedt R; Passweg JR; Tichelli A; Cazzola M; Skoda RC
N Engl J Med; 2005 Apr; 352(17):1779-90. PubMed ID: 15858187
[TBL] [Abstract][Full Text] [Related]
16. Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin.
Liu E; Jelinek J; Pastore YD; Guan Y; Prchal JF; Prchal JT
Blood; 2003 Apr; 101(8):3294-301. PubMed ID: 12515724
[TBL] [Abstract][Full Text] [Related]
17. The incidences of trisomy 8, trisomy 9 and D20S108 deletion in polycythaemia vera: an analysis of blood granulocytes using interphase fluorescence in situ hybridization.
Westwood NB; Gruszka-Westwood AM; Pearson CE; Delord CF; Green AR; Huntly BJ; Lakhani A; McMullin MF; Pearson TC
Br J Haematol; 2000 Sep; 110(4):839-46. PubMed ID: 11054066
[TBL] [Abstract][Full Text] [Related]
18. Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis.
Mitterbauer G; Winkler K; Gisslinger H; Geissler K; Lechner K; Mannhalter C
Am J Clin Pathol; 1999 Jul; 112(1):93-100. PubMed ID: 10396290
[TBL] [Abstract][Full Text] [Related]
19. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
[TBL] [Abstract][Full Text] [Related]
20. Polycythemia vera: analysis of DNA from blood granulocytes using comparative genomic hybridization.
Westwood NB; Gruszka-Westwood AM; Atkinson S; Pearson TC
Haematologica; 2001 May; 86(5):464-9. PubMed ID: 11410408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
